Here are five key points.
1. The market totaled $31.39 billion last year.
2. Between 2016 and 2025, the market is slated to increase at a 6.4 percent compound annual growth rate.
3. Factors driving growth in the ophthalmology devices market include:
• Higher prevalence of diabetes and a growing geriatric population
• Innovations in diagnostic and visualization techniques
• More awareness of advanced ophthalmic care
• Improvements in surgical procedures
4. Reimbursement challenges may hinder market growth.
5. The following companies are dominating the market: Bausch & Lomb, Essilor International, Carl Zeiss Meditec, CooperVision, Alcon, SynergEyes, Topcon Corp., Johnson & Johnson, Haag-Streit Group, Nidek Co. and Ziemer Ophthalmic Systems.
More articles on healthcare:
Common ASC coding errors: podiatry, otolaryngology & more
Dermatology & Plastic Surgery of Arizona relocating to building with surgery center — 4 key notes
Inhaled anesthetics of special risk to the environment — 5 tips to on reduce OR carbon footprints
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
